News
Merck's KEYTRUDA Combo Cuts Risk By 35% In First-Line PD-L1+ Metastatic TNBC, Phase 3 Study Confirms
(RTTNews) - Merck & Co Inc. (MRK) announced that KEYTRUDA (pembrolizumab) plus Trodelvy (sacituzumab govitecan-hziy) reduced the risk of disease progression or death by 35% compared to KEYTRUDA plus c ...
Intel’s AI Playground is one of the easiest ways to experiment with large language models (LLMs) on your own computer—without ...
Under the budget sent to Gov. McMaster, lawmakers’ in-district compensation increases to $2,500 a month. The $18,000 a year ...
Car extended warranty calls are annoying and potentially dangerous. Here's why auto warranty scams happen—and how to stop ...
Mayor Christopher Scanlon and State Sen. Sean Ryan continue to bring in big money in the race to become Buffalo’s next mayor, far outpacing other candidates as the June primary for the Democratic line ...
Attackers use business email compromise to pretend to be company executives, vendors, or other trusted parties and trick ...
With thousands of press releases published each week, it can be difficult to keep up with everything on Cision. To help ...
The Justice Department and Google have one final chance to convince a federal judge how the tech giant should change its ...
The reactionary blogger’s call for a monarch to rule the country once seemed like a joke. Now the right is ready to bend the ...
5d
How-To Geek on MSN4 Hidden Microsoft Excel Tools You Probably Didn’t KnowMicrosoft Excel has hundreds of tools and functions, meaning it's quite easy to overlook some of the most useful ones. In ...
Choosing a smartphone today is like choosing between a lavender raffa and a classic Americano: on the one hand, it's stylish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results